Results 201 to 210 of about 14,141 (248)

Risk of viral failure after simplification therapy without using integrase inhibitors compared with maintenance of triple antiretroviral therapy: A systematic review and meta-analysis. [PDF]

Braz J Infect Dis
Helfer MS, Sprinz E.
europepmc   +1 more source

Impact of HBV serological status on HIV virological efficacy of two-drug antiretroviral regimens: A retrospective observational study on virologically suppressed people with HIV switching to lamivudine/dolutegravir. [PDF]

HIV Med
Salvo PF, Ciccullo A, Visconti E, Lombardi F, Torti C, Di Giambenedetto S, Baldin G.   +6 more
europepmc   +1 more source

Patterns of peri-gestational weight change among women living with HIV in Nigeria receiving dolutegravir compared to alternative antiretroviral regimens: a retrospective cohort study. [PDF]

AIDS Res Ther
Al Naimi A, Chang C, Rawizza H, Olaifa O, Ogunsola O, Okonkwo P, Kanki P.   +6 more
europepmc   +1 more source

Comparative Analyses of Antiviral Potencies of Second-Generation Integrase Strand Transfer Inhibitors (INSTIs) and the Developmental Compound 4d Against a Panel of Integrase Quadruple Mutants. [PDF]

Viruses
Smith SJ, Zhao XZ, Hughes SH, Burke TR.
europepmc   +1 more source

SERS Detection of Hydrophobic Molecules: Thio-β-Cyclodextrin-Driven Rapid Self-Assembly of Uniform Silver Nanoparticle Monolayers and Analyte Trapping. [PDF]

Biosensors (Basel)
Yuan Q, Wang Y.
europepmc   +1 more source

Editorial: Heterodienes in organic synthesis. [PDF]

Front Chem
Sukhorukov AY.
europepmc   +1 more source

Patients reported neuropsychiatric adverse events and associated factors among PLHIV patients receiving DTG-based regimen antiretroviral therapy real-life clinical practice in Ethiopia: multi center crossetional study. [PDF]

BMC Psychiatry
Chanie GS, Belachew EA, Seid AM, Limenh LW, Mitku ML, Beyna AT, Mengesha AK, Melese M, Esubalew D, Gela YY, Ayenew W, Simegn W.   +11 more
europepmc   +1 more source

24-month outcomes after switching to Dolutegravir/Lamivudine in people living with HIV and HBcAb positivity at the Beijing Ditan Hospital in China. [PDF]

Ann Med
Fu J, Biao R, Liu Y, Chen J, Zhao H.
europepmc   +1 more source

Szegedi Orvostudományi Egyetem Gyógyszerésztudományi Kar dolgozóinak 1985. évi szakirodalmi munkássága : bibliográfia [PDF]

, 1986

core  

Pharmacogenetics of plasma dolutegravir exposure during 1-month rifapentine/isoniazid treatment of latent tuberculosis. [PDF]

Pharmacogenet Genomics
Covington N, Luetkemeyer AF, Imperial MZ, Dawson R, Cramer Y, Rosenkranz S, Swindells S, Gelmanova I, Avihingsanon A, Arduino RC, Samaneka W, Dooley KE, Savic R, Podany AT, Haas DW.   +14 more
europepmc   +1 more source